Reply
Ophthalmology
.
2018 Oct;125(10):e69-e70.
doi: 10.1016/j.ophtha.2018.03.058.
Authors
David R Weakley Jr
1
,
Michael J Lynn
2
,
Lindreth Dubois
3
,
George Cotsonis
2
,
M Edward Wilson
4
,
Edward G Buckley
5
,
David A Plager
6
,
Scott R Lambert
7
;
Infant Aphakia Treatment Study Group
Affiliations
1
Department of Ophthalmology, Southwestern University, Dallas, Texas. Electronic address: David.Weakley@Childrens.com.
2
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
3
Department of Ophthalmology, School of Medicine, Emory University, Atlanta, Georgia.
4
Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina.
5
Department of Ophthalmology, Duke University, Durham, North Carolina.
6
Glick Eye Institute, Indiana University, Indianapolis, Indiana.
7
Department of Ophthalmology, Stanford University School of Medicine, Stanford, California.
PMID:
30243340
PMCID:
PMC7815319
DOI:
10.1016/j.ophtha.2018.03.058
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Aphakia*
Humans
Infant
Lens Implantation, Intraocular*
Grants and funding
UG1 EY013287/EY/NEI NIH HHS/United States
U10 EY013272/EY/NEI NIH HHS/United States
U10 EY013287/EY/NEI NIH HHS/United States
UG1 EY025553/EY/NEI NIH HHS/United States
UG1 EY013272/EY/NEI NIH HHS/United States
P30 EY006360/EY/NEI NIH HHS/United States